Growing evidence shows that the inhibition of microglia activation by the c-Jun-NH(2)-kinase (JNK) inhibitor [74] or minocycline (a crude microglia inhibitor) [75,76] is able to delay glioma formation in the Nf1OPG mice. Here, MAPK8 is linked to glioma.